Previous Article | Next Article 
Infection and Immunity, July 2001, p. 4698-4701, Vol. 69, No. 7
0019-9567/01/$04.00+0 DOI: 10.1128/IAI.69.7.4698-4701.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Synthetic Polysaccharide Type 3-Related Di-, Tri-,
and Tetrasaccharide-CRM197 Conjugates Induce Protection
against Streptococcus pneumoniae Type 3 in Mice
Barry
Benaissa-Trouw,1,*
Dirk J.
Lefeber,2
Johannis P.
Kamerling,2
Johannes F. G.
Vliegenthart,2
Kees
Kraaijeveld,1 and
Harm
Snippe1
Vaccines Section, Eijkman-Winkler Institute for
Microbiology, Infectious Diseases and Inflammation, Utrecht Medical
Center,2 and Bijvoet Center,
Department of Bio-Organic Chemistry, Utrecht
University,1 Utrecht, The Netherlands
Received 3 November 2000/Returned for modification 6 December
2000/Accepted 29 March 2001
Di-, tri-, and tetrasaccharides, synthesized according to the
chemical structure of pneumococcal polysaccharide type 3 (PS3), were
coupled to the cross-reactive material (CRM197) of modified diphtheria toxin in different molar carbohydrate/protein ratios using
the squarate coupling method. To study protective immunity, female
BALB/c mice were subcutaneously immunized twice (with a 3-week
interval) using the amount of conjugates corresponding to 2.5 µg of
oligosaccharide per mouse. The conjugates evoked PS3 binding
immunoglobulin G antibodies that lasted for at least 7 weeks after the
booster. Immunogenicity was not influenced by the carbohydrate/protein
ratio. All mice with PS3-specific antibodies survived the
intraperitoneal challenge with Streptococcus pneumoniae type 3. Therefore, synthetic oligosaccharide-protein conjugates might
have potential as vaccines.
*
Corresponding author. Mailing address: Eijkman-Winkler
Institute for Microbiology, Infectious Diseases and Inflammation,
Vaccines Section, Utrecht Medical Center, HP G 04.614, Heidelberglaan
100, 3584 CX Utrecht, The Netherlands. Phone: 31-30-2507635. Fax:
31-30-2541770. E-mail: B.J.BenaissaTrouw{at}lab.azu.nl.
Infection and Immunity, July 2001, p. 4698-4701, Vol. 69, No. 7
0019-9567/01/$04.00+0 DOI: 10.1128/IAI.69.7.4698-4701.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Park, S., Parameswar, A. R., Demchenko, A. V., Nahm, M. H.
(2009). Identification of a Simple Chemical Structure Associated with Protective Human Antibodies against Multiple Pneumococcal Serogroups. Infect. Immun.
77: 3374-3379
[Abstract]
[Full Text]
-
Phalipon, A., Tanguy, M., Grandjean, C., Guerreiro, C., Belot, F., Cohen, D., Sansonetti, P. J., Mulard, L. A.
(2009). A Synthetic Carbohydrate-Protein Conjugate Vaccine Candidate against Shigella flexneri 2a Infection. J. Immunol.
182: 2241-2247
[Abstract]
[Full Text]
-
Safari, D., Dekker, H. A. T., Joosten, J. A. F., Michalik, D., de Souza, A. C., Adamo, R., Lahmann, M., Sundgren, A., Oscarson, S., Kamerling, J. P., Snippe, H.
(2008). Identification of the Smallest Structure Capable of Evoking Opsonophagocytic Antibodies against Streptococcus pneumoniae Type 14. Infect. Immun.
76: 4615-4623
[Abstract]
[Full Text]
-
Vulliez-Le Normand, B., Saul, F. A., Phalipon, A., Belot, F., Guerreiro, C., Mulard, L. A., Bentley, G. A.
(2008). Structures of synthetic O-antigen fragments from serotype 2a Shigella flexneri in complex with a protective monoclonal antibody. Proc. Natl. Acad. Sci. USA
105: 9976-9981
[Abstract]
[Full Text]
-
Phalipon, A., Costachel, C., Grandjean, C., Thuizat, A., Guerreiro, C., Tanguy, M., Nato, F., Vulliez-Le Normand, B., Belot, F., Wright, K., Marcel-Peyre, V., Sansonetti, P. J., Mulard, L. A.
(2006). Characterization of Functional Oligosaccharide Mimics of the Shigella flexneri Serotype 2a O-Antigen: Implications for the Development of a Chemically Defined Glycoconjugate Vaccine. J. Immunol.
176: 1686-1694
[Abstract]
[Full Text]
-
Michon, F., Moore, S. L., Kim, J., Blake, M. S., Auzanneau, F.-I., Johnston, B. D., Johnson, M. A., Pinto, B. M.
(2005). Doubly Branched Hexasaccharide Epitope on the Cell Wall Polysaccharide of Group A Streptococci Recognized by Human and Rabbit Antisera. Infect. Immun.
73: 6383-6389
[Abstract]
[Full Text]
-
Meeks, M. D., Saksena, R., Ma, X., Wade, T. K., Taylor, R. K., Kovac, P., Wade, W. F.
(2004). Synthetic Fragments of Vibrio cholerae O1 Inaba O-Specific Polysaccharide Bound to a Protein Carrier Are Immunogenic in Mice but Do Not Induce Protective Antibodies. Infect. Immun.
72: 4090-4101
[Abstract]
[Full Text]
-
Lefeber, D. J., Benaissa-Trouw, B., Vliegenthart, J. F. G., Kamerling, J. P., Jansen, W. T. M., Kraaijeveld, K., Snippe, H.
(2003). Th1-Directing Adjuvants Increase the Immunogenicity of Oligosaccharide-Protein Conjugate Vaccines Related to Streptococcus pneumoniae Type 3. Infect. Immun.
71: 6915-6920
[Abstract]
[Full Text]
-
Mawas, F., Niggemann, J., Jones, C., Corbel, M. J., Kamerling, J. P., Vliegenthart, J. F. G.
(2002). Immunogenicity in a Mouse Model of a Conjugate Vaccine Made with a Synthetic Single Repeating Unit of Type 14 Pneumococcal Polysaccharide Coupled to CRM197. Infect. Immun.
70: 5107-5114
[Abstract]
[Full Text]